GHTF clarifies ethical considerations in clinical studies guidance
This article was originally published in RAJ Devices
Executive Summary
The Global Harmonization Task Force has expanded its focus on ethical considerations in the final version of its guidance on pre-market clinical investigations for medical devices1. It has also provided clarifications on post-market clinical follow-up studies in a second guidance document2.